To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Healthcare, Defense.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H35421B5B67EC409FB969086929DDF040: 1. Short title This Act may be cited as the Chinese Laboratory Accountability and Watchful Spending Act of 2024 or the CLAWS Act of 2024.
- Section H3229C455FA3C47DCBD62D466595C203B: 2. Annual report on federally-funded biomedical research in china In this section: The term covered agency means— an Executive agency, as defined in section...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Healthcare, Defense
Primary Purpose
This bill, To require the Director of the Office of Management and Budget to submit to Congress an annual report on biomedical research funded by the United States and performed in China., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
- federal agencies and legislative administrators
Identified Costs
- federal implementing agencies
Sponsors
Legislative Progress
IntroducedMr. Langworthy (for himself, Mr. Higgins of Louisiana, and Mr. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
Key Definitions
Terms defined in this bill
a project— funded by a covered agency
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology